20Slash20 Inc., the creator of The Eye Drink, announced that it will participate in the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for Sept. 9–10, 2026, at The Westin New York Grand Central in New York City. CEO Dr. Roger Wu is set to deliver an investor presentation at 9:35 a.m. ET on Sept. 9 and will hold one-on-one meetings with investors during the event.
The conference brings together growth companies, investors, and industry professionals across life sciences and other emerging sectors, providing a platform for 20Slash20 to showcase its innovative product to a targeted audience. The company's flagship offering, The Eye Drink, is described as the world's first ready-to-drink functional beverage formulated with science-backed ingredients to support eye health for individuals who spend extended periods on phones and computers. With the increasing prevalence of screen-induced eye problems, this product addresses a growing health concern in today's digital age.
The announcement underscores the company's strategic efforts to gain visibility among potential investors and partners. By presenting at this conference, 20Slash20 aims to highlight the significance of its product in the functional beverage market and its potential for growth. The event serves as a critical opportunity for the company to articulate its value proposition and engage with key stakeholders in the investment community.
For more information about the conference or to view the full press release, interested parties can visit https://ibn.fm/tm2lT.
20Slash20's participation in this conference comes at a time when the demand for health-focused beverages is rising, particularly those that cater to the needs of technology-dependent lifestyles. The Eye Drink's unique positioning as a functional beverage for eye health could resonate with a wide consumer base, from office workers to students. The company's presentation may provide insights into its market strategy and future plans, making it a noteworthy event for investors tracking the functional beverage sector.
As the conference approaches, all eyes will be on 20Slash20 to see how it leverages this platform to advance its corporate objectives. The company's involvement in such a prestigious event signals its commitment to growth and innovation within the life sciences and consumer health industries.
